Independence Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Independence Advisors's BMY Position: Q3 2020 in Review
Independence Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.18% in Q3 2020, buying an estimated $361 and bringing the position to 3,433 shares worth $207K. The position accounts for 0.04% of the portfolio, ranked #100.
Independence Advisors first reported a position in BMY in Q4 2019 and has held it in 3 quarters since. The position peaked at $212K in Q4 2019. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.
- Independence Advisors held 3,433 shares of Bristol-Myers Squibb worth $207K as of Q3 2020.
- Independence Advisors bought 6 Bristol-Myers Squibb shares in Q3 2020, an estimated $361.
- Bristol-Myers Squibb made up 0.04% of Independence Advisors's portfolio in Q3 2020, its #100 holding.
- Independence Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 3 quarters since.
- Independence Advisors's Bristol-Myers Squibb position peaked at $212K in Q4 2019.
- 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.
Based on Independence Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.